Biodistribution of single-walled carbon nanotubes in rats

Abstract

Background: Carbon nanotube (CNT) mediated drug delivery systems have recently aroused a great deal of interest. Such delivery systems for drugs, proteins and genes have been preliminarily studied using cellular and animal models. For further study of the related biological behaviours of CNTs in vivo, a fast and convenient tracing method is particularly necessary. Methods: We adopted concentrated nitric acid/concentrated sulfuric acid oxidation combined with ultrasonication to treat SWCNTs, then detected and analyzed the samples before and after treatment by transmission electron microscopy (TEM), Fourier transform infrared spectrometry (FT-IR), energy dispersive X-ray spectrometry (EDX) and X-ray photoelectron spectroscopy (XPS). The iodogen oxidative method was used to synthesize iodinated single-walled carbon nanotubes, followed by intratracheal instillation of ¹²⁵I-labelled SWCNTs to determine their distribution in rats. Results: SWCNTs form more hydroxyl and carboxyl functional groups with no change in their essential characteristics after treatment by violet acid oxidation combined with ultrasonication. ¹²⁵I can easily form C–I covalent bonds to SWCNTs. The proportion of iodine-125 labelled SWCNTs is 46.14%, the radiochemical purity is 98.95%. In order of total radioactivity concentration in the main organs/tissues and body fluids for ¹²⁵I-SWCNTs, it was shown that trachea > urine > stomach > small intestine > serum > bladder > blood vessel > kidney > liver > lung > adrenal > femoral head > spleen > testis > thymus > thyroid > heart > fat > muscle > brain. Conclusions: In this paper, we developed a generally adoptable tracing method for studying the biodistribution of SWCNTs (single walled carbon nanotubes) in vivo. SWCNTs could be labelled with radioactive ¹²⁵I atoms. The ¹²⁵I labelling method is reliable and effective and affords a quantitative analysis of CNTs accumulated in animal tissues. This result will provide an important reference for future research into the biomedical and pharmacological applications of SWCNTs.